Hybrid Imaging Market Size & Growth Forecast 2027–2036, By Segments (End Use, Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Hybrid Imaging Market size was assessed at USD 9.4 billion in 2026 and is poised to grow at a 5.8% CAGR between 2027 and 2036, attaining USD 16.52 billion by 2036. The industry revenue for 2027 is estimated at USD 9.86 billion.

• Base Year Value (2026): USD 9.4 billion
• CAGR (2027-2036): 5.80%
• Forecast Year Value (2036): USD 16.52 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Hybrid Imaging Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for a 44.52% market share in 2026, supported by advanced diagnostic infrastructure and widespread use of hybrid imaging systems across oncology, cardiology, and neurology workflows.
  • Asia Pacific is projected to grow at a 7.01% CAGR as healthcare providers expand advanced diagnostic equipment installations and integrate hybrid imaging into more complex clinical assessments.

• Segment Momentum:

  • PET/CT Systems held a 34.24% share in 2026 due to their established clinical adoption, broad installed base, and routine use in combining metabolic and anatomical imaging across high-volume diagnostic workflows.
  • Diagnostic Imaging Centers are growing fastest because they offer specialized imaging services, greater scheduling flexibility, and higher workflow efficiency, meeting rising demand for faster outpatient diagnostic access.

• Market Expansion Drivers:

  • Rising prevalence of cancer and cardiovascular diseases driving multimodal diagnostic imaging demand.
  • Expansion of outpatient imaging centers improving access to advanced diagnostic technologies.
  • Government funding and research initiatives accelerating adoption of advanced imaging modalities.

• Leading Market Participants:

  Prominent companies in the hybrid imaging market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Digirad Corporation (United States), Bruker Corporation (United States), Mediso Medical Imaging Systems (Hungary).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 9.4 billion
  • 2027 Estimated Market Size: USD 9.86 billion.
  • Projected Market Size: USD 16.52 billion by 2036
  • Growth Forecasts: 5.8% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End Use) | PET/CT Systems (Type) | Oncology (Application)
  • Emerging Opportunity Segment: Diagnostic Imaging Centers (End Use) | PET/MR Systems (Type) | Oncology (Application)

Market Growth Drivers and Industry Trends

Rising prevalence of cancer and cardiovascular diseases driving multimodal diagnostic imaging demand

The increasing burden of cancer and cardiovascular diseases is creating greater demand for diagnostic technologies capable of providing detailed and complementary clinical information. Hybrid imaging market growth is supported by the ability of multimodal systems to combine functional, metabolic, anatomical, or structural information within a coordinated diagnostic workflow, helping clinicians evaluate complex conditions more comprehensively. As disease management increasingly depends on accurate diagnosis, staging, treatment planning, and monitoring, healthcare providers are placing greater emphasis on imaging approaches that can improve lesion characterization and support more informed clinical decisions.

Expansion of outpatient imaging centers improving access to advanced diagnostic technologies

The development of outpatient imaging facilities is broadening access to sophisticated diagnostic services beyond major hospitals and specialized medical institutions. For the hybrid imaging market, this expansion creates additional opportunities for advanced systems to be deployed closer to patients, particularly as healthcare delivery shifts toward convenient and lower-complexity outpatient settings. Increased availability of dedicated imaging centers can also support earlier diagnostic evaluation, improve referral pathways, and enable healthcare providers to manage growing imaging volumes while reducing reliance on centralized hospital-based services.

Government funding and research initiatives accelerating adoption of advanced imaging modalities

Public-sector investment in healthcare infrastructure, medical research, and diagnostic innovation can create a favorable environment for the adoption of advanced imaging technologies. Government funding programs and research initiatives can help healthcare institutions improve imaging capabilities while supporting clinical studies that demonstrate the value of multimodal diagnostic approaches. Such initiatives can also strengthen collaboration among healthcare providers, research institutions, and technology developers, encouraging the evaluation and integration of advanced imaging modalities into diagnostic and disease-management pathways.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of cancer and cardiovascular diseases driving multimodal diagnostic imaging demand	2.20%	High	North America, Europe	High	Near Term
Expansion of outpatient imaging centers improving access to advanced diagnostic technologies	2.00%	High	North America, Asia Pacific	High	Mid Term
Government funding and research initiatives accelerating adoption of advanced imaging modalities	1.80%	High	North America, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest share of the hybrid imaging market in 2026, supported by advanced healthcare infrastructure, strong adoption of sophisticated diagnostic technologies, and substantial investment in medical imaging capabilities. The region benefits from well-established hospital and diagnostic networks, a high level of clinician awareness, and growing demand for imaging modalities that combine anatomical and functional information to improve diagnostic precision. Continued emphasis on early disease detection, personalized treatment planning, and workflow efficiency is encouraging healthcare providers to adopt integrated imaging solutions. In addition, established reimbursement frameworks and ongoing technological development are helping sustain demand for advanced hybrid imaging systems.

Asia Pacific is emerging as the fastest-growing regional market, driven by expanding healthcare infrastructure, increasing investments in diagnostic facilities, and rising demand for advanced medical technologies. Growing healthcare access across developing economies is creating opportunities for broader deployment of hybrid imaging systems, while increasing awareness of early diagnosis is supporting demand for sophisticated diagnostic procedures. The expansion of hospitals and specialized medical centers, coupled with improving availability of trained healthcare professionals, is strengthening the region's capacity to adopt advanced imaging technologies. Government efforts to modernize healthcare systems and rising private-sector investment are also contributing to the region's accelerating market development.

Key Country Insights

United States

Clinical Imaging Innovation

The U.S. hybrid imaging market is expanding adoption of integrated PET/CT, PET/MRI, and SPECT/CT systems across oncology, cardiology, and neurology. U.S. healthcare providers are investing in AI-assisted image analysis and workflow optimization to improve diagnostic precision and operational efficiency.

Japan

High-Resolution Imaging Focus

Japan prioritizes hybrid imaging solutions that deliver enhanced diagnostic accuracy with optimized patient workflows. Japanese healthcare institutions are integrating next-generation imaging platforms with digital health systems to improve clinical efficiency and personalized care.

South Korea

Digital Imaging Expansion

South Korea is strengthening hybrid imaging capabilities through investments in smart hospitals and advanced diagnostic technologies. South Korean medical centers are adopting integrated imaging platforms supported by AI-enabled interpretation and connected healthcare infrastructure.

Germany

Precision Diagnostic Integration

Germany emphasizes hybrid imaging technologies that support early disease detection and multidisciplinary clinical decision-making. German hospitals continue modernizing imaging infrastructure while strengthening research collaborations focused on advanced molecular imaging applications.

France

Oncology Imaging Advancement

France is expanding hybrid imaging deployment to improve cancer diagnosis, treatment planning, and disease monitoring. French healthcare providers are focusing on coordinated imaging services and technology upgrades that enhance clinical consistency and patient management.

Italy

Hospital Modernization Support

Italy is incorporating hybrid imaging systems into hospital modernization initiatives aimed at improving diagnostic quality. Italian healthcare providers are prioritizing equipment renewal, specialist training, and integrated imaging workflows for complex disease assessment.

Segment Leadership and Growth Trends

 

End Use Segment Analysis: Hospitals (Largest Segment) vs Diagnostic Imaging Centers (Fastest-Growing Segment)

Hospitals led the hybrid imaging market with a 56.18% share in 2026, supported by their comprehensive diagnostic infrastructure, multidisciplinary clinical teams, and ability to integrate advanced imaging into broader patient-care pathways. Hybrid imaging systems combine complementary imaging modalities to provide more detailed anatomical and functional information, making them valuable across complex diagnostic and treatment planning applications. Hospitals also benefit from established imaging departments and access to specialist services, reinforcing their strong position in hybrid imaging adoption.

Diagnostic imaging centers are experiencing increasing demand as healthcare delivery becomes more specialized and diagnostic services expand beyond traditional hospital settings. These centers can provide focused imaging services with streamlined workflows and dedicated diagnostic capabilities, supporting greater accessibility to advanced imaging technologies. Rising demand for accurate disease characterization, earlier diagnosis, and specialized outpatient imaging is encouraging greater deployment of hybrid imaging systems within diagnostic imaging centers.

Type Segment Analysis: PET/CT Systems (Largest Segment) vs PET/MR Systems (Fastest-Growing Segment)

PET/CT systems accounted for 34.24% of the hybrid imaging market in 2026, reflecting their established combination of metabolic and anatomical imaging capabilities. PET/CT supports comprehensive assessment of disease activity and anatomical location, particularly in applications where precise lesion characterization and treatment planning are important. Its broad clinical utility, established workflow integration, and familiarity among healthcare professionals continue to underpin its leading position within hybrid imaging.

PET/MR systems are gaining momentum as healthcare providers increasingly seek advanced imaging solutions that combine metabolic information with high-quality soft-tissue visualization. The technology can be particularly valuable where detailed tissue characterization and functional assessment are required while limiting exposure to ionizing radiation from CT. Continued advances in imaging technology, growing interest in comprehensive diagnostic information, and demand for more specialized imaging approaches are supporting increasing adoption of PET/MR systems.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End Use	Hospitals, Diagnostic Imaging Centers, Others	Hospitals	Diagnostic Imaging Centers
Type	PET/CT Systems, SPET/CT Systems, PET/MR Systems, OCT/Fundus Imaging System, Others	PET/CT Systems	PET/MR Systems
Application	Oncology, Ophthalmology, Cardiology, Brain & Neurology, Others	Oncology	Oncology

Competitive Landscape and Market Positioning

Prominent players in the hybrid imaging market:

1. GE HealthCare Technologies Inc. (United States)

2. Siemens Healthineers AG (Germany)

3. Koninklijke Philips N.V. (Netherlands)

4. Canon Medical Systems Corporation (Japan)

5. United Imaging Healthcare Co. Ltd. (China)

6. Digirad Corporation (United States)

7. Bruker Corporation (United States)

8. Mediso Medical Imaging Systems (Hungary)

The hybrid imaging market is advancing through integration of multi-modality diagnostic systems that improve clinical accuracy and workflow efficiency. Continuous innovation is enabling more comprehensive imaging solutions for complex disease assessment. Collaborative development initiatives are further strengthening technological convergence across imaging platforms.

Industry Development/News

Company Name	Date	Key Development
Siemens Healthineers	Oct-24	Siemens Healthineers secured FDA clearance for six systems within its Artis interventional imaging portfolio. Integrating the Optiq AI imaging chain, these systems provide enhanced image quality and workflow automation for image-guided procedures. This launch expands the company's competitive footprint in advanced hybrid imaging, focusing on operational efficiency and diagnostic precision for clinical environments.
Blue Earth Diagnostics	May-23	The FDA approved Flotufolastat Fluorine-18 injection, the first radiohybrid PSMA-targeted PET imaging agent for detecting prostate cancer. This regulatory milestone provides a novel diagnostic tool for clinical assessment and treatment monitoring. The introduction of radiohybrid technology signifies a material advancement in oncological imaging capabilities, improving diagnostic accuracy for patients with suspected prostate cancer recurrence or metastasis.
Erasmus MC	Sep-24	Erasmus MC led the AMICE consortium in securing €19.6 million in funding to develop advanced multimodal imaging infrastructure. This initiative aims to accelerate the commercialization and integration of next-generation biomedical imaging technologies. By building a robust research and development ecosystem, the project strengthens the foundational infrastructure for future breakthroughs in hybrid and multimodal imaging applications.
GE HealthCare	Oct-24	GE HealthCare expanded its strategic partnership with Stanford Radiology to launch a Center of Excellence for radiology innovation. The collaboration focuses on integrating molecular imaging, CT, MR, and interventional radiology with AI and pharmaceutical diagnostics. This effort is designed to accelerate the development of next-generation hybrid imaging technologies and clinical workflows through co-innovation and data-driven research.
LAITEK	Jul-24	LAITEK launched an Advanced Hybrid Migration Service to address medical imaging data management challenges. The service is engineered to lower capital and operational costs associated with migrating, storing, and accessing large-scale diagnostic datasets. By streamlining the lifecycle of clinical information, the solution enhances data interoperability and accessibility for health systems utilizing complex hybrid imaging environments.
ZimVie Inc.	Sep-23	The FDA granted ZimVie an Investigational Device Exemption (IDE) for its Mobi-C Cervical Disc hybrid application, authorizing a clinical study for simultaneous cervical disc arthroplasty and anterior cervical discectomy and fusion. This trial allows the company to evaluate a hybrid surgical approach at adjacent levels, potentially expanding the clinical application and market positioning of its spinal implant technology.